ArticleMayo Clinic proceedings2021

Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis.

Chia Siang Kow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.